Orange Book product · Generic (ANDA)
BLEOMYCIN SULFATE
BLEOMYCIN SULFATE
At a glance
Jun 01, 1996
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 01, 1996
30 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
BLEOMYCIN SULFATE
Strength
EQ 15 UNITS BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 064084
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BLEOMYCIN SULFATE
- —BLENOXANEBrand (NDA)
NDA 050443 · BRISTOL MYERS SQUIBB
- 2019BLEOMYCIN SULFATEGeneric (ANDA)
ANDA 209439 · CIPLA
- 2018BLEOMYCIN SULFATEGeneric (ANDA)
ANDA 205030 · MEITHEAL
- 2008BLEOMYCIN SULFATEGeneric (ANDA)
ANDA 065185 · FRESENIUS KABI USA
- 2007BLEOMYCIN SULFATEGeneric (ANDA)
ANDA 065201 · PHARMACHEMIE BV
- 2001BLEOMYCIN SULFATEGeneric (ANDA)
ANDA 065042 · HIKMA
- 2000BLEOMYCIN SULFATEGeneric (ANDA)
ANDA 065033 · TEVA PHARMS USA
- 2000BLEOMYCIN SULFATEGeneric (ANDA)
ANDA 065031 · HOSPIRA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
